How do these deals generally work? Is it something likeBig Pharma X offers PAR a large deposit/upfront payment and agrees to see the Clinical Phase 3 trail through to the end, help to develop and distribute, market and guide the drug through to full development for a percentage of Revenue agreement? All up a deal could b worth, for example $1 Billion USD which then in theory increases the theoretical capital of PAR from $195 Million to $1 Billion ie 5 X? So conceptually the share price may go up by some related factor?
Ann: Paradigm (PAR) Updated Investor Presentation, page-6
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.005(1.85%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.0¢ | 27.5¢ | $109.1K | 395.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3703 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 118278 | 10 |
View Market Depth
| Last trade - 11.19am 22/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
